Literature DB >> 15557205

TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease.

Steven M Kerfoot1, Elizabeth M Long, Michael J Hickey, Graciela Andonegui, Benoit M Lapointe, Renata C O Zanardo, Claudine Bonder, Will G James, Stephen M Robbins, Paul Kubes.   

Abstract

Environmental factors strongly influence the development of autoimmune diseases, including multiple sclerosis. Despite this clear association, the mechanisms through which environment mediates its effects on disease are poorly understood. Pertussis toxin (PTX) functions as a surrogate for environmental factors to induce animal models of autoimmunity, such as experimental autoimmune encephalomyelitis. Although very little is known about the molecular mechanisms behind its function in disease development, PTX has been hypothesized to facilitate immune cell entry to the CNS by increasing permeability across the blood-brain barrier. Using intravital microscopy of the murine cerebromicrovasculature, we demonstrate that PTX alone induces the recruitment of leukocytes and of active T cells to the CNS. P-selectin expression was induced by PTX, and leukocyte/endothelial interactions could be blocked with a P-selectin-blocking Ab. P-selectin blockade also prevented PTX-induced increase in permeability across the blood-brain barrier. Therefore, permeability is a secondary result of recruitment, rather than the primary mechanism by which PTX induces disease. Most importantly, we show that PTX induces intracellular signals through TLR4, a receptor intimately associated with innate immune mechanisms. We demonstrate that PTX-induced leukocyte recruitment is dependent on TLR4 and give evidence that the disease-inducing mechanisms initiated by PTX are also at least partly dependent on TLR4. We propose that this innate immune pathway is a novel mechanism through which environment can initiate autoimmune disease of the CNS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557205     DOI: 10.4049/jimmunol.173.11.7070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  82 in total

Review 1.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

2.  Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors.

Authors:  Marie Gottar; Vanessa Gobert; Alexey A Matskevich; Jean-Marc Reichhart; Chengshu Wang; Tariq M Butt; Marcia Belvin; Jules A Hoffmann; Dominique Ferrandon
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

Review 3.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

4.  Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis.

Authors:  A Bayas; M Stasiolek; N Kruse; K V Toyka; K Selmaj; R Gold
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 5.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

6.  TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.

Authors:  Stavros Garantziotis; Zhuowei Li; Erin N Potts; James Y Lindsey; Vandy P Stober; Vasiliy V Polosukhin; Timothy S Blackwell; David A Schwartz; W Michael Foster; John W Hollingsworth
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

7.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

8.  Activation of TLR4-mediated NFkappaB signaling in hemorrhagic brain in rats.

Authors:  Weiyu Teng; Lishu Wang; Weishuang Xue; Chao Guan
Journal:  Mediators Inflamm       Date:  2010-01-31       Impact factor: 4.711

9.  Expression and Function of TLR2 on CD4 Versus CD8 T Cells.

Authors:  Sun-Mi Lee; Young-Don Joo; Su-Kil Seo
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

10.  CNS immune responses following experimental stroke.

Authors:  Dannielle Zierath; Matthew Thullbery; Jessica Hadwin; J Michael Gee; Anna Savos; Angela Kalil; Kyra J Becker
Journal:  Neurocrit Care       Date:  2009-08-28       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.